VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
MRNA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
MRNAModerna, Inc.
$196.79$78.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksMRNAQuarterly Financials

Moderna, Inc. (MRNA) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Moderna, Inc. (MRNA) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

MRNA Income Statement

Quarterly statement

MRNA Income Statement

Moderna, Inc. (MRNA) annual income statement — 10-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue1.31B145M389M678M1.02B142M107M956M1.85B221M167M2.81B1.83B344M1.84B5.15B3.22B4.57B5.94B6.95B
Revenue Growth %29.23%2.11%263.55%-29.08%-45.23%-35.75%-35.93%-66.01%1.31%-35.76%-90.91%-45.37%-43.14%-92.47%-69.06%-25.9%-33.32%8.33%240.79%1117.53%
Cost of Goods Sold318M93M955M452M1.01B119M90M739M514M115M96M929M2.24B731M792M1.92B1.1B1.38B1.02B952M
COGS % of Revenue24.22%64.14%245.5%66.67%99.21%83.8%84.11%77.3%27.71%52.04%57.48%33.03%122.39%212.5%43.09%37.25%34.16%30.25%17.12%13.7%
Gross Profit995M52M-566M226M8M23M17M217M1.34B106M71M1.88B-410M-387M1.05B3.23B2.12B3.19B4.92B6B
Gross Margin %75.78%35.86%-145.5%33.33%0.79%16.2%15.89%22.7%72.29%47.96%42.52%66.97%-22.39%-112.5%56.91%62.75%65.84%69.75%82.88%86.3%
Gross Profit Growth %12337.5%126.09%-3429.41%4.15%-99.4%-78.3%-76.06%-88.48%427.07%127.39%-93.21%-41.69%-119.34%-112.15%-78.75%-46.12%-48.38%-8.08%217.61%980.33%
Operating Expenses865M867M822M1.08B268M930M1.07B1.46B1.41B1.47B1.34B1.88B1.6B1.48B1.41B1.65B954M738M696M587M
OpEx % of Revenue65.88%597.93%211.31%159.73%26.38%654.93%997.2%153.03%76.06%664.71%800.6%66.76%87.49%430.23%76.82%32.06%29.63%16.16%11.72%8.45%
Selling, General & Admin282M216M173M308M268M230M212M351M281M268M274M470M442M332M305M375M278M211M268M201M
SG&A % of Revenue21.48%148.97%44.47%45.43%26.38%161.97%198.13%36.72%15.15%121.27%164.07%16.71%24.14%96.51%16.59%7.28%8.63%4.62%4.51%2.89%
Research & Development583M651M649M775M801M700M856M1.12B1.14B1.22B1.03B1.41B1.16B1.15B1.13B1.21B820M710M554M648M
R&D % of Revenue44.4%448.97%166.84%114.31%78.84%492.96%800%117.36%61.29%552.49%614.97%49.98%63.35%333.72%61.53%23.52%25.47%15.55%9.33%9.33%
Other Operating Expenses0000-1000K0-1000K-1000K-1000K-1000K1000K1000K00-1000K1000K-1000K-1000K-1000K-1000K
Operating Income130M-815M-1.39B-857M-260M-907M-1.05B-1.25B-70M-1.36B-1.27B6M-2.01B-1.87B-366M1.58B1.17B2.45B4.23B5.41B
Operating Margin %9.9%-562.07%-356.81%-126.4%-25.59%-638.73%-981.31%-130.33%-3.77%-616.74%-758.08%0.21%-109.89%-542.73%-19.91%30.69%36.21%53.59%71.16%77.85%
Operating Income Growth %150%10.14%-32.19%31.22%-271.43%33.46%17.06%-20866.67%96.52%27%-245.9%-99.62%-272.56%-176.3%-108.66%-70.79%-67.23%-20.08%233.89%2067%
EBITDA198M-752M-1.33B-790M-208M-850M-1.01B-1.19B-18M-1.32B-1.23B208M-1.76B-1.78B-288M1.66B1.28B2.52B4.31B5.49B
EBITDA Margin %15.08%-518.62%-341.65%-116.52%-20.47%-598.59%-944.86%-124.06%-0.97%-598.19%-736.53%7.39%-96.29%-516.57%-15.67%32.24%39.72%55.26%72.49%78.98%
EBITDA Growth %195.19%11.53%-31.45%33.39%-1055.56%35.7%17.8%-670.19%98.98%25.61%-327.08%-87.47%-237.84%-170.43%-106.69%-69.75%-64.75%-19.42%236.14%2152.88%
D&A (Non-Cash Add-back)68M63M59M67M52M57M39M60M52M41M36M202M249M90M78M80M113M76M79M78M
EBIT171M-767M-1.32B-799M-187M-817M-963M-1.18B27M-1.27B-1.16B76M-1.95B-1.74B-296M1.67B1.23B2.48B4.24B5.42B
Net Interest Income62M67M55M62M73M80M89M85M97M105M114M97M95M91M100M77M50M35M9M1M
Interest Income62M67M72M70M73M81M90M91M103M111M120M103M105M104M109M87M58M40M15M7M
Interest Expense0017M8M01M1M6M6M6M6M6M10M13M9M10M8M5M6M6M
Other Income/Expense41M48M54M58M73M89M86M62M91M84M101M64M54M118M61M75M51M27M2M0
Pretax Income171M-767M-1.33B-799M-187M-818M-964M-1.18B21M-1.28B-1.17B70M-1.96B-1.75B-305M1.66B1.22B2.47B4.23B5.41B
Pretax Margin %13.02%-528.97%-342.93%-117.85%-18.41%-576.06%-900.93%-123.85%1.13%-578.73%-697.6%2.49%-106.94%-508.43%-16.59%32.14%37.8%54.18%71.2%77.85%
Income Tax9M15M9M27M13M7M7M-64M8M010M-147M1.67B-369M-384M190M174M277M572M542M
Effective Tax Rate %5.26%-1.96%-0.67%-3.38%-6.95%-0.86%-0.73%5.41%38.1%0%-0.86%-210%-85.39%21.1%125.9%11.48%14.3%11.2%13.53%10.02%
Net Income162M-782M-1.34B-826M-200M-825M-971M-1.12B13M-1.28B-1.18B217M-3.63B-1.38B79M1.47B1.04B2.2B3.66B4.87B
Net Margin %12.34%-539.31%-345.24%-121.83%-19.68%-580.99%-907.48%-117.15%0.7%-578.73%-703.59%7.71%-198.25%-401.16%4.3%28.45%32.39%48.12%61.57%70.05%
Net Income Growth %181%5.21%-38.31%26.25%-1638.46%35.5%17.36%-616.13%100.36%7.32%-1587.34%-85.19%-448.03%-162.81%-97.84%-69.91%-68.71%-20.97%199.51%1886.52%
Net Income (Continuing)162M-782M-1.34B-826M-200M-825M-971M-1.12B13M-1.28B-1.18B217M-3.63B-1.38B79M1.47B1.04B2.2B3.66B4.87B
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.38-1.96-3.40-2.11-0.51-2.13-2.52-2.910.03-3.33-3.080.55-9.53-3.620.203.622.535.248.5811.29
EPS Growth %174.51%7.98%-34.92%27.49%-1664.42%36.04%18.18%-629.09%100.34%8.01%-1640%-84.81%-476.68%-169.08%-97.67%-67.94%-67.14%-18.89%202.11%1736.23%
EPS (Basic)0.40-1.96-3.40-2.11-0.51-2.13-2.52-2.910.03-3.33-3.080.57-9.53-3.620.203.812.675.559.0912.03
Diluted Shares Outstanding430M396M395M392M390M388M386M385M399M384M382M395M381M381M405M405M412M419M426M431M
Basic Shares Outstanding401M396M395M392M390M388M386M385M385M384M382M381M381M381M386M385M390M396M402M405M
Dividend Payout Ratio--------------------